511 related articles for article (PubMed ID: 24176089)
21. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.
Fuentes-Mattei E; Velazquez-Torres G; Phan L; Zhang F; Chou PC; Shin JH; Choi HH; Chen JS; Zhao R; Chen J; Gully C; Carlock C; Qi Y; Zhang Y; Wu Y; Esteva FJ; Luo Y; McKeehan WL; Ensor J; Hortobagyi GN; Pusztai L; Fraser Symmans W; Lee MH; Yeung SC
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24957076
[TBL] [Abstract][Full Text] [Related]
22. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
23. Osteopontin promotes aromatase expression and estradiol production in human adipocytes.
Leitner L; Jürets A; Itariu BK; Keck M; Prager G; Langer F; Grablowitz V; Zeyda M; Stulnig TM
Breast Cancer Res Treat; 2015 Nov; 154(1):63-9. PubMed ID: 26482249
[TBL] [Abstract][Full Text] [Related]
24. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
25. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.
Ray A; Nkhata KJ; Cleary MP
Int J Oncol; 2007 Jun; 30(6):1499-509. PubMed ID: 17487372
[TBL] [Abstract][Full Text] [Related]
26. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
27. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
[TBL] [Abstract][Full Text] [Related]
28. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract][Full Text] [Related]
30. Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells.
Moy I; Todorović V; Dubash AD; Coon JS; Parker JB; Buranapramest M; Huang CC; Zhao H; Green KJ; Bulun SE
Oncogene; 2015 Jan; 34(3):323-33. PubMed ID: 24413080
[TBL] [Abstract][Full Text] [Related]
31. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
32. Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines.
Hevir N; Trošt N; Debeljak N; Rižner TL
Chem Biol Interact; 2011 May; 191(1-3):206-16. PubMed ID: 21182832
[TBL] [Abstract][Full Text] [Related]
33. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
34. Obesity induced a leptin-Notch signaling axis in breast cancer.
Battle M; Gillespie C; Quarshie A; Lanier V; Harmon T; Wilson K; Torroella-Kouri M; Gonzalez-Perez RR
Int J Cancer; 2014 Apr; 134(7):1605-16. PubMed ID: 24114531
[TBL] [Abstract][Full Text] [Related]
35. The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.
Privette Vinnedge LM; Ho SM; Wikenheiser-Brokamp KA; Wells SI
PLoS One; 2012; 7(10):e46985. PubMed ID: 23071688
[TBL] [Abstract][Full Text] [Related]
36. The effect of adipocyte-macrophage crosstalk in obesity-related breast cancer.
Engin AB; Engin A; Gonul II
J Mol Endocrinol; 2019 Apr; 62(3):R201-R222. PubMed ID: 30620711
[TBL] [Abstract][Full Text] [Related]
37. Effect of obesity on breast cancer development.
Cleary MP; Grossmann ME; Ray A
Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
[TBL] [Abstract][Full Text] [Related]
38. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.
Yao-Borengasser A; Monzavi-Karbassi B; Hedges RA; Rogers LJ; Kadlubar SA; Kieber-Emmons T
Oncol Rep; 2015 Jun; 33(6):2689-94. PubMed ID: 25823469
[TBL] [Abstract][Full Text] [Related]
39. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
40. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
